Communications are one thing, my company communicates every time it signs a big contract and it details the customer and the value of the contract. That is investor communications.

This suggests alot but says nothing.

The technicals suggest mild growth today, before this PR was released. This may provided support where we may have had sideways, allowing for growth, but is not the ultimate reason.

Sorry if the reply seemed to be directed at you, I had seen another comment calling it great news and maybe should have replied to it instead of the post with the actual link.

This isn't news: there is no talk of any contract signings, just vaguely proposed increase in yield. Without customers to buy the excess yield, we'll have increased costs and that will decrease earnings. While I like growth, there needs to be companies who sign contracts for this type of news to be worthwhile.

This had no substance.

I'm still long, but PRs like this are truly fluff and while it might help form support of the PPS for a day or two, it won't cause an increase that wasnt already going to happen.

I said before, that the patent has to be challenged, and I doubt any other MMJ startup has the capital to do that... So just having it may be enough barrier to entry for smaller competitors.

The generic is because its been on the market for years and their patent is no longer applicable.

Oh, I'm not disagreeing there.. But a patent on a flavored gum or a vitamin or nutrient infused gum in unlikely to hold up when challenged.

I'm just saying to people: the patent system is a mess and its easy to get around many patents to create something similar. Think Cialis vs Viagra: both are patented, both get the same response just via different methods.

So it won't be something a dr can write a prescription for, and I ask, does it qualify as a pharmaceutical?

I'm not as familiar with European patent laws. I believe prior art has even more influence on denying a patent.

US = first to file (but prior art can invalidate)
Euro zone: First to invent.

Pharmaceutical implies prescription, implies FDA recognition and full testing if they want a US Patent that's sustainable.

I think patent law will get a shakeup here: if its illegal by federal laws, it can't be patented in the US, and even if a patent clerk overlooks that, it wouldn't hold up in federal court.

An argument could be made that it's just gum with a special flavoring: plenty of prior art in that case.

But is CBD recognized by the FDA as a medicine? I'm not aware that they do.

There are already other gums on the market that provide vitamins and nutrients... If FDA does not recognize CBD as a medicine, that means there exists prior art.

Additionally: the patent may not hold up in court, but at this stage, what MMJ company has the resources to fight a patent battle?

Could just be a nice barrier to entry: "oh, here's my patent, cease and desist... Oh you want to challenge me? See you in court, I have a $15M LoC, feeling froggy?!".

Maybe all they did was buy time and first-to-market brand value.

Here's the question: is Nicorette the only nicotine based gum delivery system on the market? That will tell you if a patent on a delivery system for a specific chemical compound is patentable... Or is the value in 'first to market' and brand recognition?

Not yet, maybe during my holiday break, too busy right now.

And both patents are very specific processes. Change the process and you can win your own patent. Patents are not indefeatable, you have to have an exact replica of their process in order to be infringing on their IP.

Yes, please do say more.

Float is in the 300+M range, do you mean Shares Authorized?

Oy, call me surprised. Going down further. I bought at .105 and now I'm saddened. Oh well, at least my position was improved none the less.

I think its safe to say nobody here should be selling, only buying if you have the cash.

I wish I had the 100s K position many of you have.. I'm scratching towards 50K every few days as sales transactions clear.

If we break the support at .102 today I would be surprised..

It's still early yet.

I certainly don't expect to break .11 (sustained) either, and would be very surprised if it did.

Oh.

Given that I expect .11 to hold.

This isn't based on technicals, this is based on my observations over the last month or so.

I agree, you can sense the political slant the moment the interviewer opens their mouth.

There is such thing as bad publicity.

I've seen a particularly hard leaning news station cut off a guest who was getting the upper hand on the interviewers who had an agenda, and the channel switched to 'breaking news' which was a presidential candidate holding a stump speech at some college: when they transitioned to the 'breaking news' their candidate of choice wasn't even on the stage yet.

MJNA must take better control of the questions being asked so opinionated blowhards don't ruin the interview: its supposed to be news and education, not one sided embarrassments.

Tripp may laugh a little, but IMO he comes across as weak as he lets them run over him. His staid and over-prepared comments don't challenge their obvious slant and he never sets them straight. He's just not quick on his feet and his wit is limited (not that he's a dim wit, he's just not on the same level as other professional speakers).

Dixie needs a professional public face, let Tripp run the business, he sucks at interviews.

I'd like to think so.. Every day has seen a gap up with quick sell-off or just a sell-off followed by slow growth. Friday hit what, .102? Today's low is .105 I think? (I'm now at work, not watching as closely, every so often I peek)... Just watch the daily lows to see where we're going by the end of the day in comparison to the day before... Things could go sideways, but the morning drop says alot about the day ahead.

I did not mention the 200M S/A increase.

We have a huge float of 300+Million, we have 750M shares outstanding. We had 600M at the end of Q2, they bumped to 750 in Q3 and in q4 they increased the S/A.

However, that really doesn't matter.

My argument is that there is a huge float and LOTS of supply for the demand. Between flippers look for pennies (including MMs) and inexperienced traders, we will always have shares being sold at the bid unless big news comes in that puts a shock to the sellers and tells them they can make even more by holding: however they won't hold for more than a few days at most.

As the old saying goes: wish in one hand and crap in the other and see which gets filled first.

"Should" is subjective: between the stock structure and large float, all demand can be met and shorters have easy access to shares.

Demand is limited to high risk takers because of two reasons:

1) still pink
2) fed/regulatory risk

Additionally, lots of flippers looking to take profit out after a few pennies or even %s of a penny because the low PPS means a bigger return for them.

We SHOULD still only have 600M S/O, then we could be seeing .20.

Supply and Demand: there's more than enough demand. We shareholders are effectively like manufacturers in the same market: we each offer identical products but we have expectations that differ our sales strategy: we are effectively competing for the same buyers with price discrimination. And there are just too many manufacturers trying to sell the same widget, this competition will keep prices down and profits low unless demand increases 10 fold.

IMEO demand will come with uplist out of pink, which requires audit, and we would see MUCH more demand if we were able to get to NASDAQ over OTCBB.

As well, the low likelihood of near term rescheduling has an influence.

I said near term: next 2 years is unlikely. Will need 15-20 more MMJ states to garner the congressional/senate voting majority necessary to change the law: the White House has no authority to change it, they could influence the DOJ/FDA/BATF, but can't force them to ignore federal law if they don't want to.

Gmatt:

Yeah, with a stock structure like that, even a small demand could have jacked up the price if nobody was selling...

There is entirely too many shareholders that are always willing to sell MJNA, what amateurs don't understand is that we will never see the similar % skyrocket.

All demand can be met, it takes great news to hint to owners that they should hold and not sell and demand will increase price...

But many flippers are only looking for a penny or 3 at this low PPS, which is huge money for them (10-30%)... That willingness to sell keeps our PPS down.

We'll see a stairstep pattern to growth, as each news element has an impact we'll find out of the support is there.. Mostly quarterly reports or PRs that tell us of mergers /acquisitions or new markets opening (distributor deals or franchising) will have sustainable results.

We could see $2, but we need a 10-20x increase in revenues. The hacks who reference Medbox just don't understand what happened nor why it happened.

I had something todo with that- that 50K etrf had 35K of my own. But this is the opening drop, it'll climb up: BUY NOW!!!!

Stop bringing up Medbox!

They had almost no float and only 13M S/O... Majority of shareholders are insiders. Any demand will drive a stock with that share structure through the roof...

We have tons of demand by comparison (volume), and we have so much float its easy to short, we won't see a $2 skyrocket. This stock's structure is horrible for get rich quick schemers, this is a slow run up kind of stock.

A skyrocket for us would be 10¢ in a day... Unless we get formal reschedule news, then who knows.

Slow and long, MJNA.

With no news, likely.

Nice.. Too bad you didn't rebuy at .10 for a huge position.

Nice.. I was hoping for a small gap up before the price drop and I placed a sell before open at .115.

I cancelled that quickly after open when I saw the trend and kicked myself for not trying to sell at .11, I was driving into work when it hit .10 and I was frustrated, I could have increased my position by 7K shares..

Bummer. No gain but no actual loss either.

You called the drop nicely, I hope you got in sub .105, I'm just glad support came back and brought it back most of the way.

Yeah, we took a hit recently, the company didn't report on time and OTC Markets placed a yield on our page.. Price dropped and just jumped back up when the yield was removed. Now we're going to be subject to the news cycle. The president of one of MJNA's subsidiaries was on CNN today, so that should help. As well, a marketing campaign around the benefits of hemp is being launched.

We should see some growth but I suspect mostly support, the fundamentals regarding the Q3 revenues/earnings support our price... The price is starting to approach hype levels, but not quite yet, the P/E is very sustainable.

Q4 is the big ticket. Get in, forget you have any shares until mid-Feb. Expect swings: lots of big swinging d***s acting like market makers (we just call them market makers) and they have large enough positions to make plays that cause significant impacts. We're expecting demand to grow and to pull those MM's drawstrings and squeeze their shorts eventually (some think sooner than others), IMHO I'm expecting that to happen in early Feb as excitement around Q4 and audit/uplist builds.

Go long, MJNA!

Up a little for now.. Probably sideways unless there's big news. Looking forward to Q4/Annual report in February as well as a completed and reported Audit and uplist out of the Pink Sheets.. Then up some (some think alot) more as uplisting out of pink draws attention of more investors.

Lol! Okay... :)

My perspective is that of a person who earned an MBA from a top 50 school (I wish I got into Wharton and could afford it, but had to settle for Tulane for convenience and cost concerns).

When in a boardroom or on the global stage: how you present yourself is critical to investor confidence. Little slip-ups cause big headaches. It's why there are entire PR firms who make alot of money doing what they do.

Ill need to see the suit: if its one of those ghetto zootsuits with stripes thicker than 2 or three threads, then he's a wannabe. If its a very fine stripe, that's elegant and tasteful. Ill also have to see his tie: a tie says alot about a man.

Anybody have a YouTube link? Ill go check to see if its online yet.

Yeah, I think wearing a pinstriped suit shows his inexperience: excited to be on CNN and got a little in over his head and went out and bought a new suit for the interview.

Not likely. Even if completely legal you know they'll push to have a law stating otherwise for service personnel.

They won't risk personnel getting buzzed in a warzone, or underway in general. It'll be in the UCMJ if they can't get a law passed, and we all know how they use the vague rules in there to bust people down.

Yeah, it's only a portion of my position. At some point ill sell to cover that vacation fund and let the rest ride. I can also afford for the price to drop way down and just liquidate my entire position to recover my vacation value and just lose my play money.

As well, I have a few months to wait for 4Q12 and audit/uplist, might even be able to wait for 1Q13.. Good thing we're traveling for Xmas, she's in no hurry.

I agree with Prizzy, not overnight.. But 10 - 15years? It would take about $4B in revenues to justify a 22.5B valuation (30 x 750M s/o).

My wife would divorce me if I waited that long to take her on a vacation :).

Daily show's primary demographic are liberals and stoners. Perfect show to promote MJNA on.

If my wife doesn't ask to book our vacation any time soon, I won't have to sell and if we hit $1 ill be able to pay off a ton of debt and surprise her with a sweet vacation. Paying off CC debt and student loans won't make me rich, but would change my life. That's alot of extra income each month.

Yeah, I think you underestimate the common investor avoidance of unaudited companies in the pink sheets.

Q3 fundamentals does not support a 150:1 P/E, $1 implies $750M valuation.

Need to see the Q4 revenues be 3-4x Q3 revenues to jump that high on fundamentals (with a moderately high P/E)